TY - JOUR AU - Penel, N. AU - Adenis, A. AU - Bocci, G. PY - 2012 DA - 2012// TI - Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going? JO - Crit Rev Oncol Hematol VL - 82 UR - https://doi.org/10.1016/j.critrevonc.2011.04.009 DO - 10.1016/j.critrevonc.2011.04.009 ID - Penel2012 ER - TY - JOUR AU - Adenis, A. AU - Ray-Coquard, I. AU - Italiano, A. AU - Chauzit, E. AU - Bui-Nguyen, B. AU - Blay, J. Y. PY - 2013 DA - 2013// TI - A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours JO - Br J Cancer VL - 109 UR - https://doi.org/10.1038/bjc.2013.648 DO - 10.1038/bjc.2013.648 ID - Adenis2013 ER - TY - JOUR AU - Penel, N. AU - Clisant, S. AU - Dansin, E. AU - Desauw, C. AU - Dégardin, M. AU - Mortier, L. PY - 2010 DA - 2010// TI - Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care JO - Br J Cancer VL - 102 UR - https://doi.org/10.1038/sj.bjc.6605623 DO - 10.1038/sj.bjc.6605623 ID - Penel2010 ER - TY - JOUR AU - Jordan, M. A. AU - Toso, R. J. AU - Thrower, D. AU - Wilson, L. PY - 1993 DA - 1993// TI - Mechanism of mitotic block and inhibition cell proliferation by taxol at low concentrations JO - Proc Natl Acad Sci VL - 90 UR - https://doi.org/10.1073/pnas.90.20.9552 DO - 10.1073/pnas.90.20.9552 ID - Jordan1993 ER - TY - JOUR AU - Foa, R. AU - Norton, L. AU - Seidman, A. D. PY - 1994 DA - 1994// TI - Taxol (paclitaxel) a novel micro-tubule agent with remarkable anti-neoplastic activity JO - Int J Clin Lab Res VL - 24 UR - https://doi.org/10.1007/BF02592403 DO - 10.1007/BF02592403 ID - Foa1994 ER - TY - STD TI - Rowinsky EK, Donehower RC. Paclitaxel (Taxol). New Engl J Med. 332:1004–14. ID - ref6 ER - TY - JOUR AU - Seidman, A. D. PY - 1995 DA - 1995// TI - The emerging role of paclitaxel in breast cancer therapy JO - Clin Cancer Res VL - 1 ID - Seidman1995 ER - TY - JOUR AU - Einsenhauer, E. A. AU - Tenbokkel Huinink, W. W. AU - Swenerton, K. D. AU - Gianni, L. AU - Myles, J. AU - van der Burg, M. E. PY - 1994 DA - 1994// TI - European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer : high dose versus low-dose and long versus short infusion JO - J Clin Oncol VL - 12 UR - https://doi.org/10.1200/JCO.1994.12.12.2654 DO - 10.1200/JCO.1994.12.12.2654 ID - Einsenhauer1994 ER - TY - JOUR AU - Markman, M. AU - Hall, J. AU - Spitz, D. AU - Weiner, S. AU - Carson, L. AU - Van Le, L. PY - 2002 DA - 2002// TI - Phase 2 trial of weekly single-agent paclitaxel in platinum/paclitaxel refractory ovarian cancer JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.09.130 DO - 10.1200/JCO.2002.09.130 ID - Markman2002 ER - TY - JOUR AU - Akerley, W. AU - Herndon, J. E. AU - Egorin, M. J. AU - Lyss, A. P. AU - Kindler, H. L. AU - Savarese, D. M. PY - 2003 DA - 2003// TI - Weekly high-dose paclitaxel in advanced lung carcinoma: a phase study with pharmacokinetics by the cancer and leukemia B group JO - Cancer VL - 97 UR - https://doi.org/10.1002/cncr.11375 DO - 10.1002/cncr.11375 ID - Akerley2003 ER - TY - JOUR AU - Arai, W. AU - Hosoya, Y. AU - Hyodo, M. AU - Haruta, H. AU - Kurashina, K. AU - Saito, S. PY - 2007 DA - 2007// TI - Doxiflurdine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1 JO - Int J Clin Oncol VL - 12 UR - https://doi.org/10.1007/s10147-006-0642-x DO - 10.1007/s10147-006-0642-x ID - Arai2007 ER - TY - JOUR AU - Juan, O. AU - Albert, A. AU - Campos, J. M. AU - Caranyana, V. AU - Muñoz, J. AU - Alberola, V. PY - 2007 DA - 2007// TI - Measurement and impact of comorbidity in elderly patients with advanced non-small cell lung cancer treated with chemotherapy. A phase II study of weekly paclitaxel JO - Acta Oncol VL - 46 UR - https://doi.org/10.1080/02841860600833178 DO - 10.1080/02841860600833178 ID - Juan2007 ER - TY - JOUR AU - Ichikawa, M. AU - Suzuki, R. AU - Kataoka, K. AU - Noda, Y. AU - Shindoh, J. AU - Matsumoto, S. PY - 2010 DA - 2010// TI - Second-line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: a multi-center phase II study JO - Lung Cancer VL - 69 UR - https://doi.org/10.1016/j.lungcan.2009.11.021 DO - 10.1016/j.lungcan.2009.11.021 ID - Ichikawa2010 ER - TY - JOUR AU - Rossi, D. AU - Dennetta, D. AU - Ugolini, M. AU - Alessandroni, P. AU - Catalano, V. AU - Fedeli, S. L. PY - 2008 DA - 2008// TI - Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study JO - Clin Lung Cancer VL - 9 UR - https://doi.org/10.3816/CLC.2008.n.043 DO - 10.3816/CLC.2008.n.043 ID - Rossi2008 ER - TY - JOUR AU - Joly, F. AU - Houédé, N. AU - Noal, S. AU - Chevreau, C. AU - Priou, F. AU - Chinet-Charrot, P. PY - 2009 DA - 2009// TI - Do patients with advanced urothelial carcinoma benefit from weekly paclitaxel chemotherapy? A GETUG phase II study JO - Clin Genitourin Cancer VL - 7 UR - https://doi.org/10.3816/CGC.2009.n.018 DO - 10.3816/CGC.2009.n.018 ID - Joly2009 ER - TY - JOUR AU - Yamamoto, N. AU - Tsurutani, J. AU - Yoshimura, N. AU - Asai, G. AU - Moriyama, A. AU - Nakagawa, K. PY - 2006 DA - 2006// TI - Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer JO - Anticancer Res VL - 26 ID - Yamamoto2006 ER - TY - JOUR AU - Camps, C. AU - Caballero, C. AU - Blasco, A. AU - Safont, M. J. AU - Berrocal, A. AU - Garde, J. PY - 2005 DA - 2005// TI - Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients: efficacy and tolerability JO - Anticancer Res VL - 25 ID - Camps2005 ER - TY - JOUR AU - Yasuda, K. AU - Igishi, T. AU - Kawasaki, Y. AU - Kato, K. AU - Matsumoto, S. AU - Katayama, S. PY - 2004 DA - 2004// TI - Phase II study of weekly paclitaxel in patients with non-small cell lung cancer who have failed previous treatments JO - Oncology VL - 66 UR - https://doi.org/10.1159/000079481 DO - 10.1159/000079481 ID - Yasuda2004 ER - TY - JOUR AU - Ceresoli, G. L. AU - Gregorc, V. AU - Cordio, S. AU - Bencardino, K. B. AU - Schipani, S. AU - Cozzarini, C. PY - 2004 DA - 2004// TI - Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer JO - Lung Cancer VL - 44 UR - https://doi.org/10.1016/j.lungcan.2003.11.006 DO - 10.1016/j.lungcan.2003.11.006 ID - Ceresoli2004 ER - TY - JOUR AU - Buccheri, G. AU - Ferrigno, D. PY - 2004 DA - 2004// TI - Second-line weekly paclitaxel in patients with inoperable non-small cell lung cancer who fail combination chemotherapy with cisplatin JO - Lung Cancer VL - 45 UR - https://doi.org/10.1016/j.lungcan.2004.01.011 DO - 10.1016/j.lungcan.2004.01.011 ID - Buccheri2004 ER - TY - JOUR AU - Esteban, E. AU - González de Sande, L. AU - Fernández, Y. AU - Corral, N. AU - Fra, J. AU - Muñiz, I. PY - 2003 DA - 2003// TI - Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy JO - Ann Oncol VL - 14 UR - https://doi.org/10.1093/annonc/mdg456 DO - 10.1093/annonc/mdg456 ID - Esteban2003 ER - TY - JOUR AU - Socinski, M. A. AU - Schell, M. J. AU - Bakri, K. AU - Peterman, A. AU - Lee, J. H. AU - Unger, P. PY - 2002 DA - 2002// TI - Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel JO - Cancer VL - 95 UR - https://doi.org/10.1002/cncr.10835 DO - 10.1002/cncr.10835 ID - Socinski2002 ER - TY - JOUR AU - Fidias, P. AU - Supko, J. G. AU - Martins, R. AU - Boral, A. AU - Carey, R. AU - Grossbard, M. PY - 2001 DA - 2001// TI - A phase II study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer JO - Clin Cancer Res VL - 7 ID - Fidias2001 ER - TY - JOUR AU - Dipasquale, M. AU - Murgia, V. AU - Veccia, A. AU - Brugnara, S. AU - Caldara, A. AU - Ferro, A. PY - 2017 DA - 2017// TI - Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer: everyday clinical practice in a single Centre JO - Anti-Cancer Drugs VL - 28 UR - https://doi.org/10.1097/CAD.0000000000000482 DO - 10.1097/CAD.0000000000000482 ID - Dipasquale2017 ER - TY - JOUR AU - Park, J. H. AU - Lee, J. L. PY - 2015 DA - 2015// TI - Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum JO - Cancer Cheother Pharmacol VL - 75 UR - https://doi.org/10.1007/s00280-014-2640-4 DO - 10.1007/s00280-014-2640-4 ID - Park2015 ER - TY - JOUR AU - Petry, V. AU - Gagliato, D. M. AU - Leal, A. I. AU - Arai, R. J. AU - Longo, E. PY - 2015 DA - 2015// TI - Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2- locally advanced breast cancer JO - Braz J Med Biol Res VL - 48 UR - https://doi.org/10.1590/1414-431X20144354 DO - 10.1590/1414-431X20144354 ID - Petry2015 ER - TY - JOUR AU - Cancello, G. AU - Bagnardi, V. AU - Sangalli, C. AU - Montagna, E. AU - Dellapasqua, S. AU - Sporchia, A. PY - 2015 DA - 2015// TI - Phase II study with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel with metronomic cyclophosphamide as a preoperative treatment of triple negative breast cancer JO - Clin Breast Cancer VL - 15 UR - https://doi.org/10.1016/j.clbc.2015.03.002 DO - 10.1016/j.clbc.2015.03.002 ID - Cancello2015 ER -